Kisspeptin could be a treatment for type-2 diabetes

21 Nov 2018


Research, presented at the Society for Endocrinology annual conference, suggests that kisspeptin can increase glucose-stimulated insulin secretion in men.

Healio


Related Topics

Adrenal Diabetes Metabolism Obesity Cardiovascular Bone Endocrine-Disrupting Chemicals Endocrine-Related Cancer Neuroendocrinology Reproduction Steroid and Steroidogenesis Thyroid

Share this story